Allakos (ALLK) Appoints Rand Sutherland and Dolca Thomas to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Montreal’s Ventus Therapeutics raises $100-million to pursue ‘Holy Grail’ disease targets Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Marc Bruxelle/iStock Editorial / Getty Images
Ventus Therapeutics Inc. is the latest in a string of Canadian biotechnology startups to land significant funds from top North American investors.
The two-year-old Montreal company has raised US$100-million led by Boston-based RA Capital Management and backed by U.S. funds BVF Partners, Casdin Capital and Cormorant Asset Management, plus Fonds de solidarité FTQ, Canada’s leading institutional investor in the sector.